Justices Experiment With Enablement Paths In Amgen IP Row

By Dani Kass (March 27, 2023, 10:28 PM EDT) -- The U.S. Supreme Court justices on Monday seemed confused as they grappled for more than an hour and a half over how many antibodies are actually covered by Amgen patents underlying the cholesterol drug Repatha, and how much experimentation it would take to reach the patents' full scope....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!